Abbott Laboratories (ABT)
NYSEHealth CareMedical DevicesSnapshot 2026-07-08
$95.09-0.78%
Close 2026-07-08 · 1-day change
Reading ABT? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ABT free→NYSEHealth CareMedical DevicesSnapshot 2026-07-08
Reading ABT? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ABT free→QuarterlyIQ Insights · ABT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | — | 44,328.0 | 41,950.0 | 40,109.0 | 43,653.0 | 43,075.0 | 34,608.0 | 31,904.0 | 20,853.0 | 20,853.0 | 20,853.0 | 20,405.0 | 19,050.0 | 21,494.0 | 39,873.9 | 38,851.3 | 29,527.6 | 29,527.6 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 20,853.0 | 20,853.0 | 20,405.0 | 19,050.0 | 21,494.0 | 39,873.9 | 38,851.3 | 29,527.6 | 29,527.6 |
| Cost of Revenues | — | 19,319.0 | 18,706.0 | 17,975.0 | 19,142.0 | 18,537.0 | 15,003.0 | 13,231.0 | 9,094.0 | — | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | 4,397.0 | 4,086.0 | 3,766.0 | 2,900.0 | 2,839.0 | 2,856.0 | 2,844.0 | 6,777.5 | 6,539.6 | 5,922.8 | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | — | 12,332.0 | 11,697.0 | 10,949.0 | 11,248.0 | 11,324.0 | 9,696.0 | 9,765.0 | 6,736.0 | 6,672.0 | 6,672.0 | 6,785.0 | 6,735.0 | 7,444.0 | 12,059.5 | 12,756.8 | 8,435.6 | 8,435.6 |
| R&D Expenses | — | 2,942.0 | 2,844.0 | 2,741.0 | 2,888.0 | 2,742.0 | 2,420.0 | 2,440.0 | — | — | — | — | — | — | — | — | — | — |
| Operating Income | — | 8,053.0 | 6,825.0 | 6,478.0 | 8,362.0 | 8,425.0 | 5,357.0 | 4,532.0 | 3,026.0 | 3,185.0 | 3,185.0 | 2,867.0 | 1,360.0 | 1,894.0 | 8,084.5 | 5,751.9 | 5,693.8 | 5,693.8 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | — | — | 637.0 | 558.0 | 533.0 | 546.0 | 670.0 | 431.0 | 431.0 | 431.0 | 163.0 | 320.0 | 347.0 | 592.4 | 530.1 | 528.5 | 528.5 |
| Interest & Investment Income | — | 308.0 | 344.0 | 385.0 | 183.0 | 43.0 | 46.0 | 94.0 | 99.0 | 99.0 | 99.0 | 105.0 | 59.0 | 59.0 | 79.2 | 85.2 | 201.2 | 201.2 |
| Net Interest Expenses | — | — | — | 252.0 | 375.0 | 490.0 | 500.0 | 576.0 | 332.0 | 332.0 | 332.0 | 58.0 | 261.0 | 288.0 | 513.2 | 444.9 | 327.2 | 327.2 |
| EBT, Incl. Unusual Items | — | 8,466.0 | 7,013.0 | 6,664.0 | 8,306.0 | 8,211.0 | 4,968.0 | 4,077.0 | 1,413.0 | 1,413.0 | 1,413.0 | 3,183.0 | (220.0) | 305.0 | 6,262.6 | 5,198.6 | — | — |
| Income Tax Expense | — | 1,942.0 | (6,389.0) | 941.0 | 1,373.0 | 1,140.0 | 497.0 | 390.0 | 350.0 | 350.0 | 350.0 | 577.0 | (457.0) | (274.0) | 299.7 | 470.2 | 1,122.1 | 1,122.1 |
| Earnings from Continuing Operations | — | — | — | — | 6,933.0 | 7,071.0 | 4,471.0 | 3,687.0 | 1,063.0 | 1,063.0 | 1,063.0 | 2,606.0 | 237.0 | 579.0 | — | — | 4,734.2 | 4,734.2 |
| Net Income | ||||||||||||||||||
| Net Income | — | 6,524.0 | 13,402.0 | 5,723.0 | 6,933.0 | 7,071.0 | 4,495.0 | 3,687.0 | 1,400.0 | 1,400.0 | 1,400.0 | 4,423.0 | 5,963.0 | 5,963.0 | — | — | — | — |
| Per Share | ||||||||||||||||||
| Basic EPS | — | 3.73 | 7.67 | 3.28 | 3.94 | 3.97 | 2.52 | 2.07 | 0.94 | 0.94 | 0.94 | 2.94 | 3.76 | 3.76 | 3.76 | 3.03 | 3.16 | 3.16 |
| Diluted EPS | — | 3.72 | 7.64 | 3.26 | 3.91 | 3.94 | 2.50 | 2.06 | 0.94 | 0.94 | 0.94 | 2.92 | 3.72 | 3.72 | 3.72 | 3.01 | 3.12 | 3.12 |
| Dividend per Share | — | 2.40 | 2.24 | 2.08 | 1.92 | — | — | — | — | — | — | — | — | — | — | 1.92 | — | — |
| Basic Weighted Avg Shares | — | 1,741.0 | 1,740.0 | 1,740.0 | 1,753.0 | 1,775.0 | 1,773.0 | 1,768.0 | 1,477.0 | 1,477.0 | 1,477.0 | 1,496.0 | 1,575.0 | 1,575.0 | 1,575.4 | 1,557.6 | 1,545.4 | 1,545.4 |
| Diluted Weighted Avg Shares | — | 1,748.0 | 1,748.0 | 1,749.0 | 1,764.0 | 1,789.0 | 1,786.0 | 1,781.0 | 1,483.0 | 1,483.0 | 1,483.0 | 1,506.0 | 1,592.0 | 1,592.0 | 1,591.8 | 1,567.4 | 1,560.8 | 1,560.8 |
| Supplemental | ||||||||||||||||||
| EBIT | — | 8,053.0 | 6,825.0 | 6,478.0 | 8,362.0 | 8,425.0 | 5,357.0 | 4,532.0 | 3,026.0 | 3,185.0 | 3,185.0 | 2,867.0 | 1,360.0 | 1,894.0 | 8,084.5 | 5,751.9 | 5,693.8 | 5,693.8 |
| Effective Tax Rate | — | 22.9% | -91.1% | 14.1% | 16.5% | 13.9% | 10.0% | 9.6% | 24.8% | 24.8% | 24.8% | 18.1% | 207.7% | -89.8% | 4.8% | 9.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.